Kamada Announces Successful Interim Results of Phase II Deposition Study with Aerosolized AAT Chiropractic Economics June 3, 2008 Kamada, a bio-pharmaceutical company (www.kamada.com) engaged in the development, manufacturing and marketing of specialty Related Posts DCs need to own chiropractic health before they can share it Parker University appoints new president National Chiropractic Health Month coming in October 123 Chiropractors donates to Life University Foundation for Chiropractic Progress highlights chiropractic in on-site corporate health clinics